Medical Cells Network Ltd. is a 100% subsidiary of eight|holding, specialised in therapies, products as well as services. We are utmost committed to our patients health improvement. Its European highly supreme management and medical teams are setting new standards. With partners we operate a specialised clinic, day clinics, as well as highly sophisticated laboratories, guaranteeing highest possible standards in regards to stem cell therapies and products. Stem cells have proven to be the future of medicine in various aspects, and carry an enormous medical potential. They are not only able to cure major common diseases, but might replace drugs as well. eight|holding is participating in the colossal stem cell development and cooperates with leaders in this particular business field.
IMMUNEO Therapeutics from Germany is on a mission to revolutionize the treatment of cancer and infectious diseases through the development of breakthrough immunizations. Through our commitment to developing highly targeted and effective immunizations, we aim to redefine the standard of care and create a world where cancer and serious infectious diseases are no longer a life-altering disease. Our innovative approach is to re-activate the immune system using a method we have developed. It harnesses patient-specific neoantigen-based peptides to provoke a robust immune response against the tumor. We analyze characteristic tumor data, because like every person, this disease has its own genetic characteristics. We achieve this through our proprietary bioinformatic platform, which integrates in-depth analysis of next-generation sequencing (NGS) data from tumor samples with advanced machine learning models. Based on this, we are able to predict and optimize the selection of neoantigens effectively, and draw up treatment plans for patients in cooperation with our doctors.
www.immuneo-therapeutics.de
